Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Other Operating Expenses: 2017-2019

  • Mimedx Group's Other Operating Expenses rose 841.35% to $2.3 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$155,000, marking a year-over-year change of. This contributed to the annual value of -$8.2 million for FY2020, which is N/A change from last year.
  • According to the latest figures from Q4 2019, Mimedx Group's Other Operating Expenses is $2.3 million, which was up 202.57% from -$2.3 million recorded in Q3 2019.
  • Mimedx Group's 5-year Other Operating Expenses high stood at $2.3 million for Q4 2019, and its period low was -$5.3 million during Q4 2017.
  • For the 3-year period, Mimedx Group's Other Operating Expenses averaged around -$1.1 million, with its median value being -$680,000 (2017).
  • Data for Mimedx Group's Other Operating Expenses shows a peak YoY increase of 841.35% (in 2019) and a maximum YoY decrease of 2,377.78% (in 2019) over the last 5 years.
  • Quarterly analysis of 3 years shows Mimedx Group's Other Operating Expenses stood at -$5.3 million in 2017, then spiked by 94.14% to -$312,000 in 2018, then skyrocketed by 841.35% to $2.3 million in 2019.
  • Its Other Operating Expenses was $2.3 million in Q4 2019, compared to -$2.3 million in Q3 2019 and -$312,000 in Q4 2018.